Pegasus Laboratories, Inc. is recalling 5,784 bottles of Proin ER (phenylpropanolamine hydrochloride) 145 mg extended-release tablets due to quality failures. The recall was initiated after multiple reports of broken tablets in bottles and stability testing showing the tablets failed to meet the required hardness standards. These 145 mg tablets were distributed to three distributors across the United States in bottles of 60 tablets.
The tablets may break or crumble within the bottle, which could result in inaccurate dosing and potentially affect the medication's extended-release properties. While the risk is considered low, compromised tablet integrity can lead to inconsistent treatment for the animal's condition.
You have 2 options:
Recall #: V-0031-2024; Quantity: 5,784 bottles
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response